SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 5.50 |
Enterprise Value ($M) | 4.31 |
Book Value ($M) | 2.76 |
Book Value / Share | 0.32 |
Price / Book | 1.99 |
NCAV ($M) | 1.44 |
NCAV / Share | 0.17 |
Price / NCAV | 3.83 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.07 |
Return on Assets (ROA) | -0.42 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.97 |
Current Ratio | 1.51 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.90 |
Assets | 8.22 |
Liabilities | 5.47 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.76 |
Operating Income | -3.92 |
Net Income | -4.37 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -6.55 |
Cash from Investing | 0.20 |
Cash from Financing | 3.09 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Sternheim Eliezer | 6.30 | ||
13G/A | Armistice Capital, Llc | 4.99 | 4.84 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
11,591 | 36,794 | 31.50 | |
4,057 | 38,912 | 10.43 | |
7,135 | 41,235 | 17.30 | |
(click for more detail) |
Similar Companies | |
---|---|
APRE – Aprea Therapeutics, Inc. | APVO – Aptevo Therapeutics Inc. |
ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
ATHA – Athira Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io